{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:35:20Z","timestamp":1790566520314,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"MUR PNRR Extended Partnership","award":["MNESYS no. PE00000006"],"award-info":[{"award-number":["MNESYS no. PE00000006"]}]},{"name":"MUR PNRR Extended Partnership","award":["DHEAL-COM no. PNC-E3- 2022-23683267"],"award-info":[{"award-number":["DHEAL-COM no. PNC-E3- 2022-23683267"]}]},{"name":"Campania Region NeuroDiaTE Project","award":["CUP E65E24002260002"],"award-info":[{"award-number":["CUP E65E24002260002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00415-025-13223-9","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:22:50Z","timestamp":1752139370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical application of age-derived cut-offs for plasma neurofilament light chain in multiple sclerosis"],"prefix":"10.1007","volume":"272","author":[{"given":"Valerio","family":"Nicolella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Varelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Sirica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Polito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniello","family":"Saviano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Fiorenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Novarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Ranucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Carotenuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Petracca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Lanzillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Brescia Morra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Terracciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2613-3090","authenticated-orcid":false,"given":"Marcello","family":"Moccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"issue":"5","key":"13223_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","volume":"20","author":"M Khalil","year":"2024","unstructured":"Khalil M et al (2024) Neurofilaments as biomarkers in neurological disorders \u2014 towards clinical application. Nat Rev Neurol 20(5):269\u2013287. https:\/\/doi.org\/10.1038\/s41582-024-00955-x","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"13223_CR2","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","volume":"90","author":"L Gaetani","year":"2019","unstructured":"Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H (2019) Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry 90(8):870\u2013881. https:\/\/doi.org\/10.1136\/jnnp-2018-320106","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"13223_CR3","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jamaneurol.2023.3997","volume":"80","author":"A Abdelhak","year":"2023","unstructured":"Abdelhak A et al (2023) Neurofilament light chain elevation and disability progression in multiple sclerosis. JAMA Neurol 80(12):1317\u20131325. https:\/\/doi.org\/10.1001\/jamaneurol.2023.3997","journal-title":"JAMA Neurol"},{"key":"13223_CR4","doi-asserted-by":"publisher","unstructured":"L. Midaglia et al, (2024) Association of magnetic resonance imaging phenotypes and serum biomarker levels with treatment response and long\u2010term disease outcomes in multiple sclerosis patients. Eur J Neurol, 31(1), e16077, https:\/\/doi.org\/10.1111\/ene.16077.","DOI":"10.1111\/ene.16077"},{"issue":"8","key":"13223_CR5","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1111\/ene.15865","volume":"30","author":"JH Schaefer","year":"2023","unstructured":"Schaefer JH et al (2023) Relevance of dedicated multiple sclerosis serum biomarkers in predicting contrast enhancement with gadolinium: Results from the <scp>REDUCE-GAD<\/scp> trial. Eur J Neurol 30(8):2393\u20132400. https:\/\/doi.org\/10.1111\/ene.15865","journal-title":"Eur J Neurol"},{"issue":"5","key":"13223_CR6","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1111\/ene.15742","volume":"30","author":"A Buchmann","year":"2023","unstructured":"Buchmann A et al (2023) High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis. Eur J Neurol 30(5):1389\u20131399. https:\/\/doi.org\/10.1111\/ene.15742","journal-title":"Eur J Neurol"},{"issue":"9","key":"13223_CR7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41582-022-00686-x","volume":"18","author":"RA Marrie","year":"2022","unstructured":"Marrie RA et al (2022) From the prodromal stage of multiple sclerosis to disease prevention. Nat Rev Neurol 18(9):559\u2013572. https:\/\/doi.org\/10.1038\/s41582-022-00686-x","journal-title":"Nat Rev Neurol"},{"key":"13223_CR8","doi-asserted-by":"publisher","unstructured":"J. Britze et al., (2025) Temporal dynamics of plasma neurofilament light in blood donors with preclinical multiple sclerosis. Neurol Neuroimmunol Neuroinflamm, 12(1):e200335. https:\/\/doi.org\/10.1212\/NXI.0000000000200335.","DOI":"10.1212\/NXI.0000000000200335"},{"issue":"1","key":"13223_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","volume":"22","author":"T Kuhlmann","year":"2023","unstructured":"Kuhlmann T et al (2023) Multiple sclerosis progression: time for a new mechanism-driven framework. Lancet Neurol 22(1):78\u201388. https:\/\/doi.org\/10.1016\/S1474-4422(22)00289-7","journal-title":"Lancet Neurol"},{"issue":"1","key":"13223_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/ene.15588","volume":"30","author":"C Camara-Lemarroy","year":"2023","unstructured":"Camara-Lemarroy C, Silva C, Gohill J, Yong VW, Koch M (2023) Serum neurofilament-light and glial fibrillary acidic protein levels in hydroxychloroquine-treated primary progressive multiple sclerosis. Eur J Neurol 30(1):187\u2013194. https:\/\/doi.org\/10.1111\/ene.15588","journal-title":"Eur J Neurol"},{"key":"13223_CR11","doi-asserted-by":"publisher","unstructured":"I. Vardakas et al. (2024) Serum neurofilament light chain and glial fibrillary acidic protein for predicting response to apheresis in steroid\u2010refractory multiple sclerosis relapses. Eur J Neurol 31(8):16323. https:\/\/doi.org\/10.1111\/ene.16323.","DOI":"10.1111\/ene.16323"},{"key":"13223_CR12","doi-asserted-by":"publisher","unstructured":"J. Simren et al., (2022) Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5\u201390 years. Brain Commun 4(4):fcac174. https:\/\/doi.org\/10.1093\/braincomms\/fcac174.","DOI":"10.1093\/braincomms\/fcac174"},{"issue":"11","key":"13223_CR13","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/acn3.51676","volume":"9","author":"L Vermunt","year":"2022","unstructured":"Vermunt L et al (2022) Age- and disease-specific reference values for neurofilament light presented in an online interactive support interface. Ann Clin Transl Neurol 9(11):1832\u20131837. https:\/\/doi.org\/10.1002\/acn3.51676","journal-title":"Ann Clin Transl Neurol"},{"issue":"12","key":"13223_CR14","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1093\/brain\/awae260","volume":"147","author":"E Monreal","year":"2024","unstructured":"Monreal E et al (2024) Serum biomarkers at disease onset for personalized therapy in multiple sclerosis. Brain 147(12):4084\u20134093. https:\/\/doi.org\/10.1093\/brain\/awae260","journal-title":"Brain"},{"issue":"3","key":"13223_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","volume":"21","author":"P Benkert","year":"2022","unstructured":"Benkert P et al (2022) Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study. Lancet Neurol 21(3):246\u2013257. https:\/\/doi.org\/10.1016\/S1474-4422(22)00009-6","journal-title":"Lancet Neurol"},{"key":"13223_CR16","doi-asserted-by":"publisher","unstructured":"Moccia M, Terracciano D, Brescia Morra V, Castaldo G (2024) Neurofilament in clinical practice: Is the multiple sclerosis community ready?. Multiple Sclerosis J 30(6): 643\u2013645. https:\/\/doi.org\/10.1177\/13524585241246536.","DOI":"10.1177\/13524585241246536"},{"issue":"23","key":"13223_CR17","doi-asserted-by":"publisher","first-page":"E2448","DOI":"10.1212\/WNL.0000000000207957","volume":"101","author":"ES Sotirchos","year":"2023","unstructured":"Sotirchos ES et al (2023) Agreement between published reference resources for neurofilament light chain levels in people with multiple sclerosis. Neurology 101(23):E2448\u2013E2453. https:\/\/doi.org\/10.1212\/WNL.0000000000207957","journal-title":"Neurology"},{"key":"13223_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2024.123115","volume":"463","author":"V Nicolella","year":"2024","unstructured":"Nicolella V et al (2024) Clinical utility of the Lumipulse\u2122 immunoassay for plasma neurofilament light chain in multiple sclerosis. J Neurol Sci 463:123115. https:\/\/doi.org\/10.1016\/j.jns.2024.123115","journal-title":"J Neurol Sci"},{"key":"13223_CR19","doi-asserted-by":"publisher","unstructured":"Polymeris AA, Coslovksy M, Aeschbacher S, et al. (2020) Serum neurofilament light in atrial fibrillation: Clinical, neuroimaging and cognitive correlates. Brain Commun 2(2), fcaa166. https:\/\/doi.org\/10.1093\/braincomms\/fcaa166.","DOI":"10.1093\/braincomms\/fcaa166"},{"issue":"S1","key":"13223_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10072-024-07787-z","volume":"45","author":"M Varelli","year":"2024","unstructured":"Varelli M, Fasano S, Varriale F, Lavano A (2024) Establishment of normal reference values for serum neurofilament light based on apparently healthy subjects aged 18\u201390 years. Neurol Sci 45(S1):37\u201337. https:\/\/doi.org\/10.1007\/s10072-024-07787-z","journal-title":"Neurol Sci"},{"issue":"19","key":"13223_CR21","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA et al (2021) New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med 385(19):1737\u20131749. https:\/\/doi.org\/10.1056\/NEJMoa2102953","journal-title":"N Engl J Med"},{"key":"13223_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-024-07772-6","author":"J Tortosa-Carreres","year":"2024","unstructured":"Tortosa-Carreres J et al (2024) Renal function\u2019s impact on serum neurofilament levels in patients with multiple sclerosis: an exploratory analysis. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-024-07772-6","journal-title":"Neurol Sci"},{"issue":"10","key":"13223_CR23","doi-asserted-by":"publisher","first-page":"E1007","DOI":"10.1212\/WNL.0000000000007032","volume":"92","author":"J Kuhle","year":"2019","unstructured":"Kuhle J et al (2019) Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology 92(10):E1007\u2013E1015. https:\/\/doi.org\/10.1212\/WNL.0000000000007032","journal-title":"Neurology"},{"key":"13223_CR24","doi-asserted-by":"publisher","unstructured":"Watanabe M, Nakamura Y, Michalak Z, et al. (2019) Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD. Neurology 93(13):e1299\u2013e1311. https:\/\/doi.org\/10.1212\/WNL.0000000000008160.","DOI":"10.1212\/WNL.0000000000008160"},{"issue":"2","key":"13223_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"issue":"7","key":"13223_CR26","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1161\/STROKEAHA.119.024941","volume":"50","author":"FK Korley","year":"2019","unstructured":"Korley FK et al (2019) Serum NfL (Neurofilament Light Chain) levels and incident stroke in adults with diabetes mellitus. Stroke 50(7):1669\u20131675. https:\/\/doi.org\/10.1161\/STROKEAHA.119.024941","journal-title":"Stroke"},{"issue":"123562","key":"13223_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jns.2025.123562","volume":"475","author":"F Novarella","year":"2025","unstructured":"Novarella F et al (2025) Neurofilament light chain and Alzheimer pathology biomarkers in elderly people with multiple sclerosis. J Neurol Sci 475(123562):2. https:\/\/doi.org\/10.1016\/j.jns.2025.123562","journal-title":"J Neurol Sci"},{"key":"13223_CR28","doi-asserted-by":"publisher","unstructured":"C. Barro et al. (2023) Serum GFAP and NfL levels differentiate subsequent progression and disease activity in patients with progressive multiple sclerosis. Neurol Neuroimmunol Neuroinflamm, 10(1), e200052, https:\/\/doi.org\/10.1212\/NXI.0000000000200052.","DOI":"10.1212\/NXI.0000000000200052"},{"key":"13223_CR29","doi-asserted-by":"publisher","unstructured":"Arroyo Pereiro P, et al., (2024) \u201cBaseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing\u2013remitting multiple sclerosis: a 20-year follow-up cohort. J Neurol 271(4): 1599\u20131609 https:\/\/doi.org\/10.1007\/s00415-023-12135-w.","DOI":"10.1007\/s00415-023-12135-w"},{"key":"13223_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/ana.27144","author":"M Protopapa","year":"2024","unstructured":"Protopapa M et al (2024) Increased disability progression in <scp> rs10191329 AA <\/scp> carriers with multiple sclerosis is preceded by neurofilament light chain elevations. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.27144","journal-title":"Ann Neurol"},{"key":"13223_CR31","doi-asserted-by":"publisher","unstructured":"Husseini L, Jung J, Boess N et al. (2024) Neurofilament light chain serum levels mirror age and disability in secondary progressive multiple sclerosis: A Cross-Sectional Study. Neurol Neuroimmunol Neuroinflamm 11(5), e200279, https:\/\/doi.org\/10.1212\/NXI.0000000000200279.","DOI":"10.1212\/NXI.0000000000200279"},{"key":"13223_CR32","doi-asserted-by":"publisher","unstructured":"Centonze D, Di Sapio A, Brescia Morra V et al. (2025) Steps toward the implementation of neurofilaments in multiple sclerosis: patient profiles to be prioritized in clinical practice. Frontiers in Neurology 16:1571605. https:\/\/doi.org\/10.3389\/fneur.2025.1571605.","DOI":"10.3389\/fneur.2025.1571605"},{"key":"13223_CR33","doi-asserted-by":"publisher","unstructured":"Sotirchos ES, Fitzgerald KC, Singh CM, et al. (2023) Associations of sNfL with clinico-radiological measures in a large MS population. Annals of Clinical and Translational Neurology 10(1):84\u201397. https:\/\/doi.org\/10.1002\/acn3.51704","DOI":"10.1002\/acn3.51704"},{"key":"13223_CR34","doi-asserted-by":"publisher","unstructured":"Fox RJ, Cree BAC, de S\u00e8ze J, et al. (2024) Temporal relationship between serum neurofilament light chain and radiologic disease activity in patients with multiple sclerosis. Neurology 102(9):e209357. https:\/\/doi.org\/10.1212\/WNL.0000000000209357","DOI":"10.1212\/WNL.0000000000209357"},{"issue":"2","key":"13223_CR35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/jn\/nxab381","volume":"152","author":"MA Beydoun","year":"2022","unstructured":"Beydoun MA et al (2022) BMI and allostatic load are directly associated with longitudinal increase in plasma neurofilament light among urban middle-aged adults. J Nutr 152(2):535\u2013549. https:\/\/doi.org\/10.1093\/jn\/nxab381","journal-title":"J Nutr"},{"key":"13223_CR36","doi-asserted-by":"publisher","unstructured":"Dittrich A, Ashton NJ, Zetterberg H, et al. (2023) Association of chronic kidney disease with plasma NfL and other biomarkers of neurodegeneration. Neurology 101(3):e277-e288., https:\/\/doi.org\/10.1212\/WNL.0000000000207419.","DOI":"10.1212\/WNL.0000000000207419"},{"issue":"8","key":"13223_CR37","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1291\/hypres.31.1559","volume":"31","author":"R Kawamoto","year":"2008","unstructured":"Kawamoto R et al (2008) An association between body mass index and estimated glomerular filtration rate. Hypertens Res 31(8):1559\u20131564. https:\/\/doi.org\/10.1291\/hypres.31.1559","journal-title":"Hypertens Res"},{"issue":"5","key":"13223_CR38","first-page":"576","volume":"20","author":"G Rostoker","year":"2007","unstructured":"Rostoker G, Andrivet P, Pham I, Griuncelli M, Adnot S (2007) A modified Cockcroft-Gault formula taking into account the body surface area gives a more accurate estimation of the glomerular filtration rate. J Nephrol 20(5):576\u2013585","journal-title":"J Nephrol"},{"key":"13223_CR39","doi-asserted-by":"publisher","unstructured":"S\u00f8ndergaard HB, Olsson A, Gustavsen S, et al. (2024) Neurofilament light in serum: Reference values and effect of risk factors for multiple sclerosis. Mult Scler Relat Disord 92:106166. https:\/\/doi.org\/10.1016\/j.msard.2024.106166","DOI":"10.1016\/j.msard.2024.106166"},{"issue":"12","key":"13223_CR40","doi-asserted-by":"publisher","first-page":"7494","DOI":"10.1007\/s00415-024-12701-w","volume":"271","author":"S Malucchi","year":"2024","unstructured":"Malucchi S et al (2024) In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting. J Neurol 271(12):7494\u20137501. https:\/\/doi.org\/10.1007\/s00415-024-12701-w","journal-title":"J Neurol"},{"issue":"1","key":"13223_CR41","doi-asserted-by":"publisher","first-page":"14798","DOI":"10.1038\/s41598-018-33158-8","volume":"8","author":"A Abdelhak","year":"2018","unstructured":"Abdelhak A, Huss A, Kassubek J, Tumani H, Otto M (2018) Serum GFAP as a biomarker for disease severity in multiple sclerosis. Sci Rep 8(1):14798. https:\/\/doi.org\/10.1038\/s41598-018-33158-8","journal-title":"Sci Rep"},{"key":"13223_CR42","doi-asserted-by":"publisher","unstructured":"Gasque-Rubio R, Cubas-Nu\u00f1ez L, Tortosa-Carreres J, et al. (2024) Comparative assessment of Simoa and Lumipulse for measuring serum neurofilament light chain in multiple sclerosis patients. Acta Neurol Scand. https:\/\/doi.org\/10.1155\/2024\/1950913.","DOI":"10.1155\/2024\/1950913"},{"key":"13223_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.105412","volume":"82","author":"D Vecchio","year":"2024","unstructured":"Vecchio D et al (2024) Serum and cerebrospinal fluid neurofilament light chains measured by SIMOA\u2122, Ella\u2122, and Lumipulse\u2122 in multiple sclerosis na\u00efve patients. Mult Scler Relat Disord 82:105412. https:\/\/doi.org\/10.1016\/j.msard.2023.105412","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"13223_CR44","doi-asserted-by":"publisher","first-page":"29135","DOI":"10.1038\/s41598-024-75290-8","volume":"14","author":"S Thebault","year":"2024","unstructured":"Thebault S et al (2024) The combination of CSF neurofilament light chain and glial fibrillary acidic protein improves the prediction of long-term confirmed disability worsening in multiple sclerosis. Sci Rep 14(1):29135. https:\/\/doi.org\/10.1038\/s41598-024-75290-8","journal-title":"Sci Rep"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13223-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13223-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13223-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T15:01:42Z","timestamp":1756652502000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13223-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["13223"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13223-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"495"}}